Literature DB >> 6176126

Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.

A Milunsky, E Alpert, J L Kitzmiller, M D Younger, R K Neff.   

Abstract

Maternal serum alpha-fetoprotein (AFP) screening of routine pregnancy is a valuable tool for the prenatal detection of neural tube defects (NTDs). Against our background experience with greater than 24,000 screened pregnancies, we have studied 411 pregnant insulin-dependent diabetic women. More than a tenfold increase (19.5/1,000) in the frequency of NTDs was observed in the offspring of these diabetic patients (p less than 0.000001). Serum AFP values were lower in diabetic than in nondiabetic women. Our data indicate that the normal standard of care for diabetic pregnancy should include serum AFP screening.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176126

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Maternal serum alpha-fetoprotein (MSAFP) patient-specific risk reporting: its use and misuse.

Authors:  J N Macri; R V Kasturi; D A Krantz; E J Cook; J W Larsen
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

Review 2.  Diabetes mellitus and the nervous system.

Authors:  P J Watkins; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

3.  Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.

Authors:  W Fuhrmann; H K Weitzel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

4.  Maternal periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case-control study.

Authors:  Patrizia De Marco; Elisa Merello; Maria Grazia Calevo; Samantha Mascelli; Daniela Pastorino; Lucia Crocetti; Pierangela De Biasio; Gianluca Piatelli; Armando Cama; Valeria Capra
Journal:  Childs Nerv Syst       Date:  2011-01-05       Impact factor: 1.475

5.  Update and Review: Maternal Serum Screening.

Authors:  K E Ormond
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

Review 6.  Primary prevention of neural-tube defects and some other congenital abnormalities by folic acid and multivitamins: history, missed opportunity and tasks.

Authors:  Andrew E Czeizel; Zoltán Bártfai; Ferenc Bánhidy
Journal:  Ther Adv Drug Saf       Date:  2011-08

7.  Maternal diabetes: the risk for specific birth defects.

Authors:  M A Ramos-Arroyo; E Rodriguez-Pinilla; J F Cordero
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

8.  Obstetrical management in diabetic pregnancy: the Copenhagen experience.

Authors:  L Mølsted-Pedersen; C Kühl
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

Review 9.  Review of neural tube defects: risk factors in parental occupation and the environment.

Authors:  B M Blatter; M van der Star; N Roeleveld
Journal:  Environ Health Perspect       Date:  1994-02       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.